182 related articles for article (PubMed ID: 38567612)
101. Evaluation of Anti-Alzheimer Activity of Synthetic Coumarins by Combination of in Vitro and in Silico Approaches.
Erdogan Orhan I; Deniz FSS; Salmas RE; Irmak S; Acar OO; Turgut GC; Sen A; Zbancioc AM; Luca SV; Skiba A; Skalicka-Woźniak K; Tataringa G
Chem Biodivers; 2022 Dec; 19(12):e202200315. PubMed ID: 36282001
[TBL] [Abstract][Full Text] [Related]
102. Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation.
Manzoor S; Prajapati SK; Majumdar S; Raza MK; Gabr MT; Kumar S; Pal K; Rashid H; Kumar S; Krishnamurthy S; Hoda N
Eur J Med Chem; 2021 Apr; 215():113224. PubMed ID: 33582578
[TBL] [Abstract][Full Text] [Related]
103. Design and Synthesis of Novel Arylisoxazole-Chromenone Carboxamides: Investigation of Biological Activities Associated with Alzheimer's Disease.
Saeedi M; Rastegari A; Hariri R; Mirfazli SS; Mahdavi M; Edraki N; Firuzi O; Akbarzadeh T
Chem Biodivers; 2020 May; 17(5):e1900746. PubMed ID: 32154628
[TBL] [Abstract][Full Text] [Related]
104. Anti-ovarian cancer potential, in silico studies, and anti-Alzheimer's disease effects of some natural compounds as cholinesterase inhibitors.
Fu M; Ji C; Yang T; Mao F; Shati AA; El-Kott AF; El-Maksoud MMA; Negm S; Ji Y
Biotechnol Appl Biochem; 2023 Jun; 70(3):1085-1099. PubMed ID: 36515452
[TBL] [Abstract][Full Text] [Related]
105. Conjugates of Tacrine and Salicylic Acid Derivatives as New Promising Multitarget Agents for Alzheimer's Disease.
Makhaeva GF; Kovaleva NV; Rudakova EV; Boltneva NP; Grishchenko MV; Lushchekina SV; Astakhova TY; Serebryakova OG; Timokhina EN; Zhilina EF; Shchegolkov EV; Ulitko MV; Radchenko EV; Palyulin VA; Burgart YV; Saloutin VI; Bachurin SO; Richardson RJ
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768608
[TBL] [Abstract][Full Text] [Related]
106. The Cholinergic Selectivity of FDA-Approved and Metabolite Compounds Examined with Molecular-Docking-Based Virtual Screening.
Gambardella MD; Wang Y; Pang J
Molecules; 2024 May; 29(10):. PubMed ID: 38792196
[TBL] [Abstract][Full Text] [Related]
107. Discovery, Structure-Based Modification,
Lu X; Li Y; Guan Q; Yang H; Liu Y; Du C; Wang L; Wang Q; Pei Y; Wu L; Sun H; Chen Y
ACS Chem Neurosci; 2024 Mar; 15(6):1135-1156. PubMed ID: 38453668
[TBL] [Abstract][Full Text] [Related]
108. Assessment of Anticholinergic and Antidiabetic Properties of Some Natural and Synthetic Molecules: An
Çomaklı V; Aygül İ; Sağlamtaş R; Kuzu M; Demirdağ R; Akincioğlu H; Adem Ş; Gülçin İ
Curr Comput Aided Drug Des; 2024; 20(5):441-451. PubMed ID: 37202895
[TBL] [Abstract][Full Text] [Related]
109. Cholinesterases and the fine line between poison and remedy.
Pope CN; Brimijoin S
Biochem Pharmacol; 2018 Jul; 153():205-216. PubMed ID: 29409903
[TBL] [Abstract][Full Text] [Related]
110. Naturally Occurring Cholinesterase Inhibitors from Plants, Fungi, Algae, and Animals: A Review of the Most Effective Inhibitors Reported in 2012-2022.
Murray AP; Biscussi B; Cavallaro V; Donozo M; Rodriguez SA
Curr Neuropharmacol; 2024; 22(10):1621-1649. PubMed ID: 37357520
[TBL] [Abstract][Full Text] [Related]
111. Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer's Disease: Nexus of Cholinergic and Nerve Growth Factor Dysfunction.
Moss DE; Perez RG
Curr Alzheimer Res; 2021; 18(13):1010-1022. PubMed ID: 34911424
[TBL] [Abstract][Full Text] [Related]
112. Sulfonamide Derivatives: Recent Compounds with Potent Anti-alzheimer's Disease Activity.
Egbujor MC
Cent Nerv Syst Agents Med Chem; 2024; 24(1):82-104. PubMed ID: 38275073
[TBL] [Abstract][Full Text] [Related]
113. Sequential Contrastive and Deep Learning Models to Identify Selective Butyrylcholinesterase Inhibitors.
Ozalp MK; Vignaux PA; Puhl AC; Lane TR; Urbina F; Ekins S
J Chem Inf Model; 2024 Apr; 64(8):3161-3172. PubMed ID: 38532612
[TBL] [Abstract][Full Text] [Related]
114. Novel Dual-Acting Hybrids Targeting Type-2 Cannabinoid Receptors and Cholinesterase Activity Show Neuroprotective Effects In Vitro and Amelioration of Cognitive Impairment In Vivo.
Mugnaini C; Brizzi A; Paolino M; Scarselli E; Castelli R; de Candia M; Gambacorta N; Nicolotti O; Kostrzewa M; Kumar P; Mahmoud AM; Borgonetti V; Iannotta M; Morace A; Galeotti N; Maione S; Altomare CD; Ligresti A; Corelli F
ACS Chem Neurosci; 2024 Mar; 15(5):955-971. PubMed ID: 38372253
[TBL] [Abstract][Full Text] [Related]
115. Synthesis, biological evaluation, and computational studies of
Al-Rifai NM; Al-Khalileh NM; Zahra JA; El-Barghouthi MI; Darras FH
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2281264. PubMed ID: 37985494
[TBL] [Abstract][Full Text] [Related]
116. Novel Substituted Pyrimidine Derivatives as Potential Anti-Alzheimer's Agents: Synthesis, Biological, and Molecular Docking Studies.
Pant S; Kumar K R; Rana P; Anthwal T; Ali SM; Gupta M; Chauhan M; Nain S
ACS Chem Neurosci; 2024 Feb; 15(4):783-797. PubMed ID: 38320262
[TBL] [Abstract][Full Text] [Related]
117. Inhibition of Acetylcholinesterase by Novel Lupinine Derivatives.
Schepetkin IA; Nurmaganbetov ZS; Fazylov SD; Nurkenov OA; Khlebnikov AI; Seilkhanov TM; Kishkentaeva AS; Shults EE; Quinn MT
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110594
[TBL] [Abstract][Full Text] [Related]
118. Identification of cholinesterases inhibitors from flavonoids derivatives for possible treatment of Alzheimer's disease:
Sadeghi M; Seyedebrahimi S; Ghanadian M; Miroliaei M
Curr Res Struct Biol; 2024; 7():100146. PubMed ID: 38707547
[TBL] [Abstract][Full Text] [Related]
119. Amino-7,8-dihydro-4H-chromenone derivatives as potential inhibitors of acetylcholinesterase and butyrylcholinesterase for Alzheimer's disease management; in vitro and in silico study.
Asadipour A; Pourshojaei Y; Mansouri M; Mahdavizadeh E; Irajie C; Mottaghipisheh J; Faghih-Mirzaei E; Mahdavi M; Iraji A
BMC Chem; 2024 Apr; 18(1):70. PubMed ID: 38600537
[TBL] [Abstract][Full Text] [Related]
120. Sulphated Fucooligosaccharide from Sargassum Horneri: Structural Analysis and Anti-Alzheimer Activity.
Zhang LJ; Zhang HZ; Liu YW; Tang M; Jiang YJ; Li FN; Guan LP; Jin QH
Neurochem Res; 2024 Jun; 49(6):1592-1602. PubMed ID: 38305960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
